Cauberghs M, Clement J, Van de Woestijne K P
Laboratorium voor Pneumologie, Campus Gasthuisberg, Leuven, Belgium.
Am Rev Respir Dis. 1993 Feb;147(2):379-84. doi: 10.1164/ajrccm/147.2.379.
In a study of two groups of healthy males matched for age, smoking habits, and duration of follow-up, but differing in the rapidity of decline of FEV1 and/or vital capacity (VC), we measured lung volumes before and after bronchodilator inhalation, forced expiratory flows, diffusion capacity for CO (DLCO), and total respiratory impedance. A discriminant analysis showed that the separation between the two groups was achieved best by DLCO, weight, and FEV1/VC among the smokers and by body height and DLCO among the nonsmokers. The fact that DLCO turns out to discriminate between people with a rapid and a normal spirographic decline in the present group points to the possibility of using this measurement, in combination with FEV1/VC and weight, as a predictor of rapid decline of lung function in middle-aged healthy male smokers.
在一项针对两组年龄、吸烟习惯和随访时长相匹配,但第一秒用力呼气容积(FEV1)和/或肺活量(VC)下降速度不同的健康男性的研究中,我们测量了支气管扩张剂吸入前后的肺容积、用力呼气流量、一氧化碳弥散量(DLCO)和总呼吸阻抗。判别分析表明,吸烟者中两组之间的区分最佳指标是DLCO、体重和FEV1/VC,非吸烟者中则是身高和DLCO。在本研究组中DLCO能够区分肺功能图快速下降和正常下降的人群,这一事实表明,将该测量指标与FEV1/VC和体重相结合,有可能作为中年健康男性吸烟者肺功能快速下降的预测指标。